Activation of phospholipase A2 by 1-palmitoyl-2-(9'-oxo-nonanoyl)-sn-glycero-3-phosphocholine in vitro

Biochimica et Biophysica Acta - Biomembranes

Volumn 1798, Issue 8, 2010, Pages 1593-1600

  Code, Christian ^a   Mahalka, Ajay K ^a   Bry, Kristian ^a   Kinnunen, Paavo K J ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Oligomerization; Oxidized phospholipids; Phospholipase A2; PoxnoPC

Indexed keywords

DIPALMITOYLPHOSPHATIDYLCHOLINE; GLYCEROPHOSPHORYLCHOLINE; PHOSPHOLIPASE A2; THIOFLAVINE;

ARTICLE; CONTROLLED STUDY; COVALENT BOND; ENZYME ACTIVATION; ENZYME SUBSTRATE; HYDROLYSIS; IN VITRO STUDY; PH; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION;

ANIMALS; BEE VENOMS; ENZYME ACTIVATION; FLUORESCENT DYES; KINETICS; MICROSCOPY, ELECTRON, TRANSMISSION; MULTIPROTEIN COMPLEXES; OXIDATIVE STRESS; PHOSPHATIDYLCHOLINES; PHOSPHOLIPASES A2; SPECTROMETRY, FLUORESCENCE; THIAZOLES;

EID: 77953713611     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2010.05.002     Document Type: Article

References (87)

1. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine 2007, Oxford University Press, Oxford, United Kingdom.
2. Babior B.M., Kipnes R.S., Curnutte J.T. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J. Clin. Invest. 1973, 52:741-744.
3. Cohen D., DeLeo V.A. Ultraviolet radiation-induced phospholipase A2 activation occurs in mammalian cell membrane preparations. Photochem. Photobiol. 1993, 57:383-390.
4. Schlame M., Haupt R., Wiswedel I., Kox W.J., Rustow B. Identification of short-chain oxidized phosphatidylcholine in human plasma. J. Lipid Res. 1996, 37:2608-2615.
5. Galeotti T., Borrello S., Minotti G., Palombini G., Masotti L., Sartor G., Cavatorta P., Arcioni A., Zannoni C. Lipid composition, physical state, and lipid peroxidation of tumor membranes. Toxicol. Pathol. 1984, 12:324-330.
6. Galeotti T., Borrello S., Palombini G., Masotti L., Ferrari M.B., Cavatorta P., Arcioni A., Stremmenos C., Zannoni C. Lipid peroxidation and fluidity of plasma membranes from rat liver and Morris hepatoma 3924A. FEBS Lett. 1984, 169:169-173.
7. Masotti L., Casali E., Gesmundo N., Sartor G., Galeotti T., Borrello S., Piretti M.V., Pagliuca G. Lipid peroxidation in cancer cells: chemical and physical studies. Ann. N. Y. Acad. Sci. 1988, 551:47-57. discussion 57-8.
8. Zhang X.Y., Tan Y.L., Cao L.Y., Wu G.Y., Xu Q., Shen Y., Zhou D.F. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics. Schizophr. Res. 2006, 81:291-300.
9. Schoenberg M.H., Buchler M., Schadlich H., Younes M., Bultmann B., Beger H.G. Involvement of oxygen radicals and phospholipase A2 in acute pancreatitis of the rat. Klin. Wochenschr. 1989, 67:166-170.
10. Kourie J.I. Interaction of reactive oxygen species with ion transport mechanisms. Am. J. Physiol. 1998, 275:C1-C24.
11. Kinnunen P.K.J. On the principles of functional ordering in biological membranes. Chem. Phys. Lipids 1991, 57:375-399.
12. Kinnunen P.K.J. Lipid bilayers as osmotic response elements. Cell. Physiol. Biochem. 2000, 10:243-250.
13. Kinnunen P.K.J. Amyloid formation on lipid membrane surfaces. TBIOJ 2009, 2:163.
14. Esterbauer H., Eckl P., Ortner A. Possible mutagens derived from lipids and lipid precursors. Mutat. Res. 1990, 238:223-233.
15. Six D.A., Dennis E.A. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim. Biophys. Acta 2000, 1488:1-19.
16. Salgo M.G., Corongiu F.P., Sevanian A. Enhanced interfacial catalysis and hydrolytic specificity of phospholipase A2 toward peroxidized phosphatidylcholine vesicles. Arch. Biochem. Biophys. 1993, 304:123-132.
17. Pieterson W.A., Vidal J.C., Volwerk J.J., de Haas G.H. Zymogen-catalyzed hydrolysis of monomeric substrates and the presence of a recognition site for lipid-water interfaces in phospholipase A2. Biochemistry 1974, 13:1455-1460.
18. van den Berg J.J., Op den Kamp J.A., Lubin B.H., Kuypers F.A. Conformational changes in oxidized phospholipids and their preferential hydrolysis by phospholipase A2: a monolayer study. Biochemistry 1993, 32:4962-4967.
19. Kinnunen P.K.J. Fusion of lipid bilayers: a model involving mechanistic connection to HII phase forming lipids. Chem. Phys. Lipids 1992, 63:251-258.
20. Sabatini K., Mattila J.P., Megli F.M., Kinnunen P.K.J. Characterization of two oxidatively modified phospholipids in mixed monolayers with DPPC. Biophys. J. 2006, 90:4488-4499.
21. Kambayashi Y., Yamamoto Y., Nakano M. Preferential hydrolysis of oxidized phosphatidylcholine in cholesterol-containing phosphatidylcholine liposome by phospholipase A2. Biochem. Biophys. Res. Commun. 1998, 245:705-708.
22. Wells M.A. The mechanism of interfacial activation of phospholipase A2. Biochemistry 1974, 13:2248-2257.
23. Verger R., Mieras M.C., de Haas G.H. Action of phospholipase A at interfaces. J. Biol. Chem. 1973, 248:4023-4034.
24. Tatulian S.A., Biltonen R.L., Tamm L.K. Structural changes in a secretory phospholipase A2 induced by membrane binding: a clue to interfacial activation?. J. Mol. Biol. 1997, 268:809-815.
25. Tatulian S.A. Toward understanding interfacial activation of secretory phospholipase A2 (PLA2): membrane surface properties and membrane-induced structural changes in the enzyme contribute synergistically to PLA2 activation. Biophys. J. 2001, 80:789-800.
26. Bell J.D., Biltonen R.L. The temporal sequence of events in the activation of phospholipase A2 by lipid vesicles. Studies with the monomeric enzyme from Agkistrodon piscivorus piscivorus. J. Biol. Chem. 1989, 264:12194-12200.
27. Hazlett T.L., Deems R.A., Dennis E.A. Activation, aggregation, inhibition and the mechanism of phospholipase A2. Adv. Exp. Med. Biol. 1990, 279:49-64.
28. Hille J.D., Egmond M.R., Dijkman R., van Oort M.G., Jirgensons B., de Haas G.H. Aggregation of porcine pancreatic phospholipase A2 and its zymogen induced by submicellar concentrations of negatively charged detergents. Biochemistry 1983, 22:5347-5353.
29. Grainger D.W., Reichert A., Ringsdorf H., Salesse C. Hydrolytic action of phospholipase A2 in monolayers in the phase transition region: direct observation of enzyme domain formation using fluorescence microscopy. Biochim. Biophys. Acta 1990, 1023:365-379.
30. Maloney K.M., Grandbois M., Salesse C., Grainger D.W., Reichert A. Membrane microstructural templates for enzyme domain formation. J. Mol. Recognit. 1996, 9:368-374.
31. Burack W.R., Yuan Q., Biltonen R.L. Role of lateral phase separation in the modulation of phospholipase A2 activity. Biochemistry 1993, 32:583-589.
32. Code C., Domanov Y., Jutila A., Kinnunen P.K.J. Amyloid-type fiber formation in control of enzyme action: interfacial activation of phospholipase A2. Biophys. J. 2008, 95:215-224.
33. Chibowski E., Holysz L., Jurak M. Effect of lipolytic enzyme on wettability and topography of phospholipid layers deposited on solid support. Colloid. Surf. A: Physiocochem. Eng. Aspects 2008, 321:131-136.
34. Chiu C.R., Huang W.N., Wu W.G., Yang T.S. Fluorescence single-molecule study of cobra phospholipase A2 action on a supported gel-phase lipid bilayer. Chem. Phys. Chem. 2009, 10:549-558.
35. Code C., Domanov Y.A., Killian J.A., Kinnunen P.K.J. Activation of phospholipase A(2) by temporin B: formation of antimicrobial peptide-enzyme amyloid-type cofibrils. Biochim. Biophys. Acta 2009.
36. Zhao H., Jutila A., Nurminen T., Wickstrom S.A., Keski-Oja J., Kinnunen P.K.J. Binding of endostatin to phosphatidylserine-containing membranes and formation of amyloid-like fibers. Biochemistry 2005, 44:2857-2863.
37. LeVine H. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 1993, 2:404-410.
38. LeVine H. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 1999, 309:274-284.
39. Khurana R., Coleman C., Ionescu-Zanetti C., Carter S.A., Krishna V., Grover R.K., Roy R., Singh S. Mechanism of thioflavin T binding to amyloid fibrils. J. Struct. Biol. 2005, 151:229-238.
40. Thuren T., Virtanen J.A., Kinnunen P.K.J. Polyamine-phospholipid interaction probed by the accessibility of the phospholipid sn-2 ester bond to the action of phospholipase A2. J. Membr. Biol. 1986, 92:1-7.
41. Thuren T., Virtanen J.A., Verger R., Kinnunen P.K.J. Hydrolysis of 1-palmitoyl-2-[6-(pyren-1-yl)]hexanoyl-sn-glycero-3-phospholipids by phospholipase A2: effect of the polar head-group. Biochim. Biophys. Acta 1987, 917:411-417.
42. Thuren T., Virtanen J.A., Somerharju P.J., Kinnunen P.K.J. Phospholipase A2 assay using an intramolecularly quenched pyrene-labeled phospholipid analog as a substrate. Anal. Biochem. 1988, 170:248-255.
43. Zhao H., Kinnunen P.K.J. Modulation of the activity of secretory phospholipase A2 by antimicrobial peptides. Antimicrob. Agents Chemother. 2003, 47:965-971.
44. Sanchez S.A., Bagatolli L.A., Gratton E., Hazlett T.L. A two-photon view of an enzyme at work: Crotalus atrox venom PLA2 interaction with single-lipid and mixed-lipid giant unilamellar vesicles. Biophys. J. 2002, 82:2232-2243.
45. T. Honger, Interplay between dynamic properties and functionality of biomembranes, dynamic microstructure, MEmbrane Flexibility, and Morphological Instability Induced by Phospholipase A2. Doctoral Thesis, (1994) 100.
46. P. Hoyrup, Phospholipase A2 activity in relation to the physical properties of lipid bilayers, Doctoral Thesis, (2001) 130.
47. Bell J.D., Biltonen R.L. The temporal sequence of events in the activation of phospholipase A2 by lipid vesicles. Studies with the monomeric enzyme from Agkistrodon piscivorus piscivorus. J. Biol. Chem. 1989, 264:12194-12200.
48. Code C., Domanov Y., Jutila A., Kinnunen P.K.J. Amyloid-type fiber formation in control of enzyme action: interfacial activation of phospholipase A2. Biophys. J. 2008, 95:215-224.
49. Mauro M., Craparo E.F., Podesta A., Bulone D., Carrotta R., Martorana V., Tiana G., San Biagio P.L. Kinetics of different processes in human insulin amyloid formation. J. Mol. Biol. 2007, 366:258-274.
50. Itabe H., Yamamoto H., Suzuki M., Kawai Y., Nakagawa Y., Suzuki A., Imanaka T., Takano T. Oxidized phosphatidylcholines that modify proteins. Analysis by monoclonal antibody against oxidized low density lipoprotein. J. Biol. Chem. 1996, 271:33208-33217.
51. Kurvinen J.P., Kuksis A., Ravandi A., Sjovall O., Kallio H. Rapid complexing of oxoacylglycerols with amino acids, peptides and aminophospholipids. Lipids 1999, 34:299-305.
52. Steinbrecher U.P. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J. Biol. Chem. 1987, 262:3603-3608.
53. Mattila J.P., Sabatini K., Kinnunen P.K.J. Oxidized phospholipids as potential molecular targets for antimicrobial peptides. Biochim. Biophys. Acta 2008, 1778:2041-2050.
54. Scott D.L., White S.P., Otwinowski Z., Yuan W., Gelb M.H., Sigler P.B. Interfacial catalysis: the mechanism of phospholipase A2. Science 1990, 250:1541-1546.
55. Ghomashchi F., Lin Y., Hixon M.S., Yu B.Z., Annand R., Jain M.K., Gelb M.H. Interfacial recognition by bee venom phospholipase A2: insights into nonelectrostatic molecular determinants by charge reversal mutagenesis. Biochemistry 1998, 37:6697-6710.
56. Lin Y., Ghomashchi F., Nielsen R., Snitko Y., Yu B.Z., Han S.K., Cho W., Wilton D.C., Jain M.K., Robinson B.H., Gelb M.H. Binding of bee venom and human group IIa phospholipases A2 to membranes: a minor role for electrostatics. Biochem. Soc. Trans. 1998, 26:341-345.
57. Koppaka V., Axelsen P.H. Accelerated accumulation of amyloid beta proteins on oxidatively damaged lipid membranes. Biochemistry 2000, 39:10011-10016.
58. Koppaka V., Paul C., Murray I.V., Axelsen P.H. Early synergy between Abeta42 and oxidatively damaged membranes in promoting amyloid fibril formation by Abeta40. J. Biol. Chem. 2003, 278:36277-36284.
59. Griffin M.D., Mok M.L., Wilson L.M., Pham C.L., Waddington L.J., Perugini M.A., Howlett G.J. Phospholipid interaction induces molecular-level polymorphism in apolipoprotein C-II amyloid fibrils via alternative assembly pathways. J. Mol. Biol. 2008, 375:240-256.
60. Mattila J.P., Sabatini K., Kinnunen P.K.J. Oxidized phospholipids as potential novel drug targets. Biophys. J. 2007, 93:3105-3112.
61. Khurana R., Coleman C., Ionescu-Zanetti C., Carter S.A., Krishna V., Grover R.K., Roy R., Singh S. Mechanism of thioflavin T binding to amyloid fibrils. J. Struct. Biol. 2005, 151:229-238.
62. Megli F.M., Russo L., Sabatini K. Oxidized phospholipids induce phase separation in lipid vesicles. FEBS Lett. 2005, 579:4577-4584.
63. Greenberg M.E., Li X.M., Gugiu B.G., Gu X., Qin J., Salomon R.G., Hazen S.L. The lipid whisker model of the structure of oxidized cell membranes. J. Biol. Chem. 2008, 283:2385-2396.
64. Wong-ekkabut J., Xu Z., Triampo W., Tang M.I., Tieleman D.P., Monticelli L. Effect of lipid peroxidation on the properties of lipid bilayers: a molecular dynamics study. Biophys. J. 2007, 93:4225-4236.
65. Sevanian, Kim E. Phospholipase A2 dependent release of fatty acids from peroxidized membranes. J. Free Radic. Biol. Med. 1985, 1:263-271.
66. Sevanian M.L., Wratten L.L., McLeod, Kim E. Lipid peroxidation and phospholipase A2 activity in liposomes composed of unsaturated phospholipids: a structural basis for enzyme activation. Biochim. Biophys. Acta 1988, 961:316-327.
67. van Kuijk F.J.M., Sevanian A., Handelman G.J., Dratz E.A. A new role for phospholipase A2: protection of membranes from lipid peroxidation damage. TIBS 1987, 12:31.
68. Nigam S., Schewe T. Phospholipase A(2)s and lipid peroxidation. Biochim. Biophys. Acta 2000, 1488:167-181.
69. Chaitidis P., Schewe T., Sutherland M., Kuhn H., Nigam S. 15-Lipoxygenation of phospholipids may precede the sn-2 cleavage by phospholipases A2: reaction specificities of secretory and cytosolic phospholipases A2 towards native and 15-lipoxygenated arachidonoyl phospholipids. FEBS Lett. 1998, 434:437-441.
70. Yip C.M., McLaurin J. Amyloid-beta peptide assembly: a critical step in fibrillogenesis and membrane disruption. Biophys. J. 2001, 80:1359-1371.
71. Gorbenko G.P., Kinnunen P.K.J. The role of lipid-protein interactions in amyloid-type protein fibril formation. Chem. Phys. Lipids 2006, 141:72-82.
72. Op den Kamp J.A., Kauerz M.T., van Deenen L.L. Action of pancreatic phospholipase A2 on phosphatidylcholine bilayers in different physical states. Biochim. Biophys. Acta 1975, 406:169-177.
73. Wagner K., Desbat B., Brezesinski G. Liquid-liquid immiscibility in model membranes activates secretory phospholipase A2. Biochim. Biophys. Acta 2008, 1778:166-174.
74. Bosco D.A., Fowler D.M., Zhang Q., Nieva J., Powers E.T., Wentworth P., Lerner R.A., Kelly J.W. Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization. Nat. Chem. Biol. 2006, 2:249-253.
75. Bieschke J., Zhang Q., Powers E.T., Lerner R.A., Kelly J.W. Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation. Biochemistry 2005, 44:4977-4983.
76. Bieschke J., Zhang Q., Bosco D.A., Lerner R.A., Powers E.T., Wentworth P., Kelly J.W. Small molecule oxidation products trigger disease-associated protein misfolding. Acc. Chem. Res. 2006, 39:611-619.
77. Siegel S.J., Bieschke J., Powers E.T., Kelly J.W. The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation. Biochemistry 2007, 46:1503-1510.
78. Brame C.J., Boutaud O., Davies S.S., Yang T., Oates J.A., Roden D., Roberts L.J. Modification of proteins by isoketal-containing oxidized phospholipids. J. Biol. Chem. 2004, 279:13447-13451.
79. Cordella-Miele E., Miele L., Mukherjee A.B. A novel transglutaminase-mediated post-translational modification of phospholipase A2 dramatically increases its catalytic activity. J. Biol. Chem. 1990, 265:17180-17188.
80. Cunningham T.J., Yao L., Lucena A. Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties. J. Inflamm. (Lond) 2008, 5:17.
81. Hatters D.M., Lawrence L.J., Howlett G.J. Sub-micellar phospholipid accelerates amyloid formation by apolipoprotein C-II. FEBS Lett. 2001, 494:220-224.
82. Andersen C.B., Yagi H., Manno M., Martorana V., Ban T., Christiansen G., Otzen D.E., Goto Y., Rischel C. Branching in amyloid fibril growth. Biophys. J. 2009, 96:1529-1536.
83. Kayed R., Bernhagen J., Greenfield N., Sweimeh K., Brunner H., Voelter W., Kapurniotu A. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J. Mol. Biol. 1999, 287:781-796.
84. Wilson L.M., Mok Y.F., Binger K.J., Griffin M.D., Mertens H.D., Lin F., Wade J.D., Gooley P.R., Howlett G.J. A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis. J. Mol. Biol. 2007, 366:1639-1651.
85. Lettinga M., Zuilhof H., van Zandvoortc M. Phosphorescence and fluorescence characterization of fluorescein derivatives immobilized in various polymer matrices. Phys. Chem. Chem. Phys. 2000, 2:3697-3707.
86. Schroder T., Kivilaakso E., Kinnunen P.K.J., Lempinen M. Serum phospholipase A2 in human acute pancreatitis. Scand. J. Gastroenterol. 1980, 15:633-636.
87. Adibhatla R.M., Hatcher J.F. Altered lipid metabolism in brain injury and disorders. Subcell. Biochem. 2008, 49:241-268.